We are live on ! Find out more
OREX

Orexigen Therapeutics, Inc.
OREX

Delisted

OREX was delisted on the 3rd of April, 2018.

Back to rankings

123 hedge funds and large institutions have $442M invested in Orexigen Therapeutics, Inc. in 2013 Q2 according to their latest regulatory filings, with 123 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

59% more call options, than puts

Call options by funds: $10.4M | Put options by funds: $6.53M

Holders
123
Holders Change
+123
Holders Change %
–
% of All Funds
4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
123
Increased
–
Reduced
–
Closed
–
Calls
$10.4M
Puts
$6.53M
Net Calls
+$3.87M
Net Calls Change
+$3.87M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

OREX Hedge Fund Activity: Q2 2013 in Review

123 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Orexigen Therapeutics, Inc. (OREX) for Q2 2013, worth a combined $442M.

Buyers outnumbered sellers: 123 funds opened new OREX positions and 0 closed out — a net gain of 123 holders — while 0 added to existing stakes and 0 trimmed.

  • 123 institutional investors held Orexigen Therapeutics, Inc. (OREX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $442M of Orexigen Therapeutics, Inc. stock for Q2 2013.
  • 123 funds opened new Orexigen Therapeutics, Inc. positions in Q2 2013 and 0 closed out, a net change of +123 holders.

Based on aggregated 13F filings for Q2 2013.